Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
TAA-based DNA vaccines show promise against metastatic disease
June 30th, 2005
Tumor associated antigen-based DNA vaccines show promise against metastatic disease in breast cancer patients. According to recent research published in the journal Breast Cancer Research and Treatment, "Anti-tumor vaccines are a relatively non-toxic alternative to conventional chemotherapeutic strategies to control breast cancer. Immunization with tumor-associated antigens (TAAs) triggers anti-tumor cytotoxic T lymphocytes (CTL), which can limit tumor progression." R.K. Sypniewska and associates at the University of Texas explained, "Here we report on the development and effectiveness of a TAA-based DNA vaccine encoding Mage-b1/2, the mouse...
Source: Women's Health Weekly (2005-06-30)
|
